Public Profile

MEDPACE INC

Medpace Inc., headquartered in the United States, is a leading global contract research organisation (CRO) that has been at the forefront of clinical development since its founding in 1992. With a strong presence in North America, Europe, and Asia, Medpace offers comprehensive services across various therapeutic areas, including oncology, cardiology, and infectious diseases. The company is renowned for its integrated approach to clinical trial management, providing a unique combination of regulatory expertise and operational excellence. Medpace's commitment to quality and efficiency has positioned it as a trusted partner for pharmaceutical and biotechnology companies worldwide. Notable achievements include a consistent track record of successful trial completions and a growing portfolio of innovative solutions tailored to meet the evolving needs of the industry.

DitchCarbon Score

How does MEDPACE INC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

MEDPACE INC's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

MEDPACE INC's reported carbon emissions

Medpace Inc, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of emissions data suggests that Medpace may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for companies like Medpace to establish clear climate commitments and reduction targets to align with global efforts in mitigating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. MEDPACE INC's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. MEDPACE INC is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

MEDPACE INC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Pharmacosmos

DK
Health Services
Updated 11 days ago

Royal Melbourne Hospital

AU
Health Services
Updated 1 day ago

REDSTAR PHARMACEUTICAL

CN
Health Services
Updated 11 days ago

Cepham Inc

US
Health Services
Updated 11 days ago

Fortune Pharmaceutical Co

CN
Health Services
Updated 11 days ago

SAFE Health Systems

US
Health Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers